Haemonetics (HAE) EPS (Basic) (2009 - 2026)

Haemonetics' EPS (Basic) history runs 18 years deep, the most recent figure standing at -$0.43 for Q1 2026.

• On a quarterly basis, EPS (Basic) fell 137.07% year-over-year to -$0.43 in Q1 2026; TTM through Mar 2026 was $2.06, a 38.08% decrease from a year earlier, with the FY2026 full-year figure at $2.06, down 38.09% from the prior year.
• EPS (Basic) eased to -$0.43 in Q1 2026 per HAE's latest filing, from $0.96 in the prior quarter.
• Across five years, EPS (Basic) topped out at $1.15 in Q1 2025 and bottomed at -$0.43 in Q1 2026.
• The 5-year median for EPS (Basic) is $0.65 (2022), against an average of $0.59.
• Across the five-year window, EPS (Basic) surged 543.79% in 2022 and slumped 137.07% in 2026, its largest moves.
• Year by year, EPS (Basic) stood at $0.65 in 2022, then fell by 5.65% to $0.62 in 2023, then gained by 21.24% to $0.75 in 2024, then advanced by 28.16% to $0.96 in 2025, then slumped by 144.66% to -$0.43 in 2026.
• Per Business Quant, the three latest HAE EPS (Basic) figures stand at -$0.43 (Q1 2026), $0.96 (Q4 2025), and $0.81 (Q3 2025).